Why BGPT?
logo

Graphs Built From Reported Results

Turn exact figures reported in papers into graphs, each point traced to its source.Know what the science actually supports before you trust the answer.

Press Enter ↵ to create graph



    Explore by Goal












     Quick Explanation


    Visual summary — Torres et al. (2026) CRPA Mexico collection (n=136)

    Primary findings: 38% carry carbapenemase genes; 75% harbour disruptive oprD variants; resistance mechanisms vary by PAO1-like vs PA14-like lineages; ST309 frequent — integrated phylogenomics + phenotypes support lineage-specific non-carbapenemase adaptation




     Long Explanation


    Author: Magali Torres — Visual, evidence-first review of Torres et al. (2026)

    Data-driven figures below visualize the core experimental results from the study of 136 Mexican clinical Pseudomonas aeruginosa isolates (2021–2023). All claims are directly supported by the cited paper.

    Source breakdown reported by the authors: blood 35%, bronchial 17%, urine 13%, other 35% ()

    Key numbers: 38% of isolates carried carbapenemase genes (VIM, GES, IMP); ~75% had potentially disruptive oprD variants (nonsense/frameshift/insertions); efflux-pump (mex) overexpression observed in a substantial subset, particularly after antibiotic exposure (qRT-PCR subset)

    Authors report that PAO1-like and PA14-like phylogroups dominate and show different resistance signatures: PAO1-like isolates were enriched for disruptive oprD variants, while carbapenemase genes were more frequent in certain PA14/PAO1 contexts; a distinct P. paraeruginosa lineage was identified in the collection

    Authors observed that carbapenemase-harbouring isolates (CEG+) tended to show shorter lag phases under carbapenem exposure compared with non-CEG isolates, which often showed prolonged lag — consistent with different adaptive responses tied to resistance mechanism

    Interpretation & limitations (evidence-first)

    • Lineage context matters: PAO1-like vs PA14-like clustering correlated with different resistance mechanisms (CEGs vs oprD disruption/efflux patterns), supporting lineage-driven adaptation ().
    • Non-carbapenemase mechanisms are common: the high frequency of oprD disruption (~75%) and observed mex overexpression indicate that loss-of-porin + efflux upregulation are major contributors to carbapenem resistance in this collection ().
    • Limitations noted by authors: gene-expression assays were performed on a small subset (n=18), AmpC expression data are missing, antibiotic exposures varied per-isolate (MIC-adjusted) which limits direct cross-isolate comparisons, and no patient outcome links were made — these constrain causal inference and generalizability ().

    Data availability & reproducibility

    Raw sequencing reads are available at NCBI SRA under PRJNA1211528 and analysis tools/commands are listed (Trim Galore, Unicycler, Panaroo, IQ-TREE2, Snippy, ABRicate) supporting reproducibility (

    What would falsify the authors' main conclusion?

    Evidence that phylogenetic background is unrelated to distribution of resistance determinants (CEGs, oprD variants, efflux expression), or that phenotypes (MICs, growth-lag responses) do not correlate with genomic markers would undermine the lineage-driven adaptation claim ().



    Feedback:    

    Updated: March 17, 2026

     BGPT Author Review


    Scientific Quality

    70%

    The author demonstrates strong empirical competence: integrated genomics, phenotyping, WGS analysis, resistome characterization and qRT-PCR were executed with appropriate tools and transparent data deposition; sample size (n=136) and diverse collection strengthen inference. Deductions about lineage-specific mechanisms are well-supported but limited by a small expression subset (n=18), absence of AmpC expression data, and variable per-isolate antibiotic exposures which reduce cross-isolate comparability; these reduce maximal score.


    Communication Quality

    80%

    The manuscript presents clear figures, methods, and integrated results with actionable conclusions; data availability and tool lists improve reproducibility. Minor clarity limits: some quantitative breakdowns (exact lineage counts, ST309 frequency counts) could be more explicit in main text/tables, and expression-sample selection criteria need fuller justification.


    Author Novelty

    70%

    Combining large-scale WGS with phenotypic growth kinetics and targeted qRT-PCR across a 136-isolate clinical collection provides novel insight into lineage-specific non-carbapenemase resistance in Mexico; not wholly unprecedented globally but regionally and methodologically valuable.


    Scientific Rigor

    70%

    Methods use appropriate, modern bioinformatics pipelines and controls; raw data deposition aids reproducibility. Rigor limited by small n for expression experiments, per-isolate MIC-tailored antibiotic exposures (reducing uniformity), and missing AmpC quantification — these create interpretive blindspots.

     Analysis Wizard



    Loading PRJNA1211528 metadata and computing per-isolate presence/absence matrices for carbapenemase genes, oprD disruptive variants, and MLST to reproduce lineage-mechanism associations.



     Hypothesis Graveyard


    Hypothesis: Carbapenemase genes are the primary driver of resistance in this collection — falsified by the high (~75%) oprD disruption rate and frequent efflux upregulation, showing non-carbapenemase mechanisms dominate numerically.


    Hypothesis: Lineage has no effect on resistance mechanism distribution — contradicted by clear PAO1-like versus PA14-like differences reported by the authors.

     Science Art


    Author: Magali Torres Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending